![Stuart Duty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stuart Duty
Directeur/Membre du Conseil chez
EYEPOINT, INC.
Fortune : - $ au 30/06/2026
Profil
Stuart M.
Duty is an Independent Director at EyePoint, Inc. since 2023, an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. since 2024, and an Independent Director at Foghorn Therapeutics, Inc. since 2025.
Former roles include Managing Director-Healthcare Investment Banking at Montgomery Securities, Inc. from 1993 to 1999, Senior Managing Director at Guggenheim Partners LLC from 2012 to 2023, Managing Director at Piper Jaffray, Inc. from 1992 to 2002, Director-Business Development at Curative Technologies, Inc. from 1992 to 1993, Independent Director at Achieve Life Sciences, Inc. from 2023 to 2026, and Chief Operating Officer at Oracle Partners LP from 2002 to 2007.
Education includes undergraduate studies at Occidental College and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
| 10/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
EYEPOINT, INC. -.--% | 21/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| 24/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Stuart Duty
| Sociétés | Poste | Début |
|---|---|---|
| EYEPOINT, INC. | Directeur/Membre du Conseil | 16/10/2023 |
| MILESTONE PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 14/07/2024 |
| FOGHORN THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/05/2025 |
Anciens postes connus de Stuart Duty
| Sociétés | Poste | Fin |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 02/07/2026 |
Guggenheim Partners LLC
 Guggenheim Partners LLC Investment ManagersFinance Provides investment and financial services | Corporate Officer/Principal | 01/03/2023 |
Oracle Partners LP | Directeur des opérations | 01/01/2007 |
Piper Jaffray, Inc.
 Piper Jaffray, Inc. Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 01/01/2002 |
Montgomery Securities, Inc.
 Montgomery Securities, Inc. Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 01/01/1999 |
Formation de Stuart Duty
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
Oracle Partners LP | |
Montgomery Securities, Inc.
Montgomery Securities, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Curative Technologies, Inc.
 Curative Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Biopharmaceutical research | Commercial Services |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Occidental College
 Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guggenheim Partners LLC
Guggenheim Partners LLC Investment ManagersFinance Provides investment and financial services | Finance |
Piper Jaffray, Inc.
Piper Jaffray, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Choisissez Zonebourse 
